First-In-Human Study of AK1320 Encapsulated Microspheres (AK1320 MS)
Clinical trial NCT04483297 · TERMINATED
Trial details
- NCT number
- NCT04483297
- Sponsor
- Asahi Kasei Therapeutics Corporation
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-11-18
- Primary completion
- 2023-11-27
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.